Jonathan L. Curry

7.9k total citations · 1 hit paper
197 papers, 4.7k citations indexed

About

Jonathan L. Curry is a scholar working on Oncology, Dermatology and Molecular Biology. According to data from OpenAlex, Jonathan L. Curry has authored 197 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Oncology, 73 papers in Dermatology and 52 papers in Molecular Biology. Recurrent topics in Jonathan L. Curry's work include Cutaneous Melanoma Detection and Management (52 papers), Melanoma and MAPK Pathways (38 papers) and Cutaneous lymphoproliferative disorders research (38 papers). Jonathan L. Curry is often cited by papers focused on Cutaneous Melanoma Detection and Management (52 papers), Melanoma and MAPK Pathways (38 papers) and Cutaneous lymphoproliferative disorders research (38 papers). Jonathan L. Curry collaborates with scholars based in United States, Australia and Spain. Jonathan L. Curry's co-authors include Víctor G. Prieto, Michael T. Tetzlaff, Carlos A. Torres‐Cabala, J. J. Trentin, Priyadharsini Nagarajan, Phyu P. Aung, Doina Ivan, Roland L. Bassett, Brian J. Nickoloff and Michael A. Davies and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Jonathan L. Curry

184 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NRAS mutation status is an independent prognostic factor in metastatic melanoma

2011 528 citations Roland L. Bassett, Jonathan L. Curry et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan L. Curry United States	35	2.4k	1.8k	905	895	583	197	4.7k
William Damsky United States	32	1.6k 0.7×	1.9k 1.0×	1.4k 1.6×	838 0.9×	483 0.8×	122	4.7k
Marie‐Françoise Avril France	45	3.6k 1.5×	2.0k 1.1×	1.5k 1.6×	953 1.1×	1.1k 1.9×	161	6.2k
Stefania Staibano Italy	43	2.4k 1.0×	2.8k 1.6×	730 0.8×	646 0.7×	725 1.2×	229	6.5k
Hong Wu United States	39	3.2k 1.4×	3.7k 2.1×	1.2k 1.3×	542 0.6×	561 1.0×	102	7.5k
Mai P. Hoang United States	39	2.0k 0.9×	1.2k 0.7×	337 0.4×	1.0k 1.1×	857 1.5×	207	4.8k
Uwe Reinhold Germany	35	1.3k 0.6×	1.0k 0.6×	1.0k 1.1×	980 1.1×	647 1.1×	132	3.6k
Klaus Griewank Germany	28	2.5k 1.1×	2.0k 1.1×	1.7k 1.9×	312 0.3×	393 0.7×	82	5.3k
Eva‐B. Bröcker Germany	36	1.2k 0.5×	1.3k 0.7×	1.2k 1.3×	476 0.5×	259 0.4×	92	4.9k
Mohammed Kashani–Sabet United States	47	4.5k 1.9×	3.9k 2.2×	1.3k 1.4×	1.1k 1.3×	1.4k 2.4×	182	7.7k
Toshiaki Saida Japan	41	2.6k 1.1×	1.6k 0.9×	680 0.8×	1.5k 1.7×	1.3k 2.2×	182	4.7k

Countries citing papers authored by Jonathan L. Curry

Since Specialization

Citations

This map shows the geographic impact of Jonathan L. Curry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan L. Curry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan L. Curry more than expected).

Fields of papers citing papers by Jonathan L. Curry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan L. Curry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan L. Curry. The network helps show where Jonathan L. Curry may publish in the future.

Co-authorship network of co-authors of Jonathan L. Curry

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan L. Curry. A scholar is included among the top collaborators of Jonathan L. Curry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan L. Curry. Jonathan L. Curry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pacha, Omar, Anisha B. Patel, Jonathan L. Curry, et al.. (2025). Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 13(8). e011401–e011401. 1 indexed citations

Torres‐Cabala, Carlos A., Auris Huen, Guilin Tang, et al.. (2025). Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma with novel FGFR1 fusion treated with pemigatinib. Blood Advances. 9(8). 1786–1790.

Marques‐Piubelli, Mario L., Courtney W. Hudgens, Rossana Lazcano, et al.. (2024). Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides. Cells. 13(5). 419–419.

Aung, Phyu P., Jing Ning, Priyadharsini Nagarajan, et al.. (2024). TRPS1 expression in non-melanocytic cutaneous neoplasms: an immunohistochemical analysis of 200 cases. Journal of Pathology and Translational Medicine. 58(2). 72–80. 9 indexed citations

Collins, Katrina, Phyu P. Aung, Priyadharsini Nagarajan, et al.. (2023). TRPS1 expression in primary and secondary extramammary Paget diseases: An immunohistochemical analysis of 93 cases. Human Pathology. 143. 5–9. 11 indexed citations

Tang, Zhenya, Phyu P. Aung, Priyadharsini Nagarajan, et al.. (2023). Lymphomatoid papulosis with DUSP22–IRF4 rearrangement: A case report and literature review. Journal of Cutaneous Pathology. 50(8). 711–716. 3 indexed citations

Ronen, Shira, Jonathan L. Curry, Priyadharsini Nagarajan, et al.. (2023). Phenotypic switch in mycosis fungoides: A tertiary cancer center experience. Human Pathology. 142. 27–33.

Johnson, Daniel H., Anisha B. Patel, Marc Uemura, et al.. (2019). IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy. Cancer Immunology Research. 7(6). 860–865. 91 indexed citations

Sagiv, Oded, Jonathan L. Curry, Jing Ning, et al.. (2018). High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma. OncoImmunology. 7(9). e1475874–e1475874. 23 indexed citations

10.

Tetzlaff, Michael T., Jonathan L. Curry, Jing Ning, et al.. (2018). Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations. Clinical Cancer Research. 25(4). 1280–1290. 41 indexed citations

11.

Tetzlaff, Michael T., Priyadharsini Nagarajan, Susan Y. Chon, et al.. (2017). Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features. American Journal of Dermatopathology. 39(2). 121–129. 82 indexed citations

12.

Nagarajan, Priyadharsini, Jonathan L. Curry, Jing Ning, et al.. (2016). Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases. Clinical Cancer Research. 23(8). 2093–2104. 37 indexed citations

13.

Feldmeyer, Laurence, Courtney W. Hudgens, Priyadharsini Nagarajan, et al.. (2016). Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma. Clinical Cancer Research. 22(22). 5553–5563. 86 indexed citations

14.

Estrella, Jeannelyn S., Michael T. Tetzlaff, Roland L. Bassett, et al.. (2015). Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing. Molecular Cancer Therapeutics. 14(12). 2887–2895. 33 indexed citations

15.

Jahan‐Tigh, Richard R., et al.. (2014). A verrucous presentation of mycosis fungoides - eScholarship. Dermatology Online Journal. 20(8). 1 indexed citations

16.

Ching, Grace, Sandra S. Ojeda, Charles H. Adelmann, et al.. (2013). Sorafenib Suppresses JNK-Dependent Apoptosis through Inhibition of ZAK. Molecular Cancer Therapeutics. 13(1). 221–229. 25 indexed citations

17.

Zhao, Chengquan, S. Barron, Haijun Zhou, et al.. (2013). Dermatopathology. Laboratory Investigation. 93. 110–125. 1 indexed citations

18.

Richards, Hunter W., Qiushi Lin, Carlos A. Torres‐Cabala, et al.. (2012). H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma. Journal of Skin Cancer. 2012. 1–9. 11 indexed citations

19.

Tawil, Rabi, Nagi F. Khouri, Carlos A. Torres‐Cabala, et al.. (2010). Education. Laboratory Investigation. 90. 123–125. 1 indexed citations

20.

Bandyopadhyay, Debdutta, Jonathan L. Curry, Qiushi Lin, et al.. (2007). Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi. Aging Cell. 6(4). 577–591. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact